Clinical trial
Effects of an Anti-Inflammatory Drug in Alzheimer's Disease
NCT00013650 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00013650 |
|---|---|
| Title | Effects of an Anti-Inflammatory Drug in Alzheimer's Disease |
| Official title | Pilot Study of Immunomodulatory Versus Antiinflammatory Therapy in Alzheimer's Disease |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | Cyclophosphamate |
| Enrollment | 60 |
| Start date | Mar 22, 2001 |
| Completion | Apr 21, 2008 |
| First posted | Mar 28, 2001 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: